Banque Pictet & Cie’s Soleno Therapeutics SLNO Stock Holding History

Banque Pictet & Cie’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,730	Closed	-$1.3M	–	386
2026 Q1	$1.3M	Sell	38,730 -5,066	-12%	-$199K	0.01%	262
2025 Q4	$2.03M	Buy	+43,796	New	+$2.4M	0.01%	215

Banque Pictet & Cie's SLNO Position: Q2 2026 in Review

Banque Pictet & Cie sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 38,730 shares — an estimated $1.3M sold.

Banque Pictet & Cie first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $2.03M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Banque Pictet & Cie reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Banque Pictet & Cie sold 38,730 Soleno Therapeutics shares in Q2 2026, an estimated $1.3M.
Banque Pictet & Cie first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Banque Pictet & Cie's Soleno Therapeutics position peaked at $2.03M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.